Zika virus (ZIKV) is an arthropod-borne Flavivirus that is spread by infected Aedes mosquitoes. The accurate diagnosis of ZIKV can be complicated due to a variety of factors, including analogous clinical presentation, serological cross-reactivity, or the possibility of co-infection with other co-circulated viruses such as dengue virus and chikungunya virus. Thus, the accurate and rapid diagnosis of vector-borne diseases through validated diagnostic methods is critical in enabling prompt treatment and controlling viral dissemination.

To support critical ongoing research on this virus, ATCC offers ZIKV virus reference materials and solutions for the development of novel vaccines, treatment protocols, and innovative therapeutics. Our portfolio includes in vivo and cell culture–adapted strains, genomic and synthetic nucleic acid preparations, high-titer and heat-inactivated viral preparations, monoclonal antibodies, and host cell lines and reagents. Explore our portfolio of Zika virus research materials below.